Defining the biologically active dose for PTK787/ZK222584 (ptk/zk), a vascular endothelial growth factor (VEGF) receptor inhibitor, based on the assessment of two biomarkers [dynamic contrast enhanced magnetic resonance imaging (DCE-MRI), plasma VEGF] in two phase I studies

• Book ID: 117659581
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 141 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)80889-9